Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients with Chest Wall Breast Cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1)

被引：1
|
作者：
Valenza, Carmine
Giachetti, Pier Paolo Maria Berton
Zagami, Paola
Nicolo, Eleonora
Trapani, Dario
Boldrini, Laura
Salimbeni, Beatrice Taurelli
Ascione, Liliana
Antonarelli, Gabriele
Corti, Chiara
Esposito, Angela
Criscitiello, Carmen
Fusco, Nicola
Curigliano, Giuseppe
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-14-05
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [22] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [23] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    MODERN PATHOLOGY, 2017, 30 : 199A - 199A
  • [24] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    LABORATORY INVESTIGATION, 2017, 97 : 199A - 199A
  • [25] Foci of Programmed Cell Death-Ligand 1 (PD-L1)-positive Tumor Areas With Tumor-infiltrating Leukocytes (TILs) Evocative of a PD-1/PD-L1-related Adaptive Immune Resistance are Frequent in Merkel Cell Carcinoma
    Benigni, Paolo
    Guenole, Morgan
    Bonsang, Benjamin
    Marcorelles, Pascale
    Schick, Ulrike
    Uguen, Arnaud
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 17 - 22
  • [26] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [27] PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION STATUS IN PENILE SQUAMOUS CELL CARCINOMA TUMOR CELLS AND TUMOR INFILTRATING IMMUNE CELLS
    Rider, Jennifer
    Harlow, Alyssa
    Giunchi, Francesca
    Carlsson, Jessica
    Kirrander, Peter
    Fiorentino, Michelangelo
    Andren, Ove
    Davidsson, Sabina
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1129 - E1130
  • [28] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Nam, Soo Jeong
    Kim, Young-Hoon
    Park, Ji Eun
    Ra, Young-shin
    Khang, Shin Kwang
    Cho, Young Hyun
    Kim, Jeong Hoon
    Sung, Chang Ohk
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 305 - 318
  • [29] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Soo Jeong Nam
    Young-Hoon Kim
    Ji Eun Park
    Young-shin Ra
    Shin Kwang Khang
    Young Hyun Cho
    Jeong Hoon Kim
    Chang Ohk Sung
    Cancer Immunology, Immunotherapy, 2019, 68 : 305 - 318
  • [30] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
12345